1[1]Weitz JI,Buller HR.Direct thrombin inhibitors in acute coronary syndromes.Circulation,2002,105:1004-1011.
2[2]Sarich TC,Wolzt M,Eriksson UG,et al.Effects of ximelagatran,an oral direct thrombin inhibitor,r-hirudin and enoxaparin on thrombin generation and platelet activation in healthy male subjects.J Am Coll Cardio,2003,41:557-564.
3[3]The Direct Thrombin Inhibitor Trialists' Collaborative Group.Direct thrombin inhibitors in acute coronary syndromes:principal results of a meta-analysis based on individual patients' data.Lancet,2002,359:294-302.
4[4]Organisation to Assess Strategies for Ischemic Syndromes (OASIS) Investigators.Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation:a pilot study.Circulation,1997,96:769-777.
5[5]Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.Effects of recombinant hirudin (lepirudin) compared with heparin on death,myocardial infarction,refractory angina,and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation:a randomised trial.Lancet,1999,353:429-438.
6[6]The Global Use of Strategies to Open Occluded Arteries (GUSTO) Ⅱb Investigators.A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes.N Engl J Med,1996,335:775-782.
7[7]White H.The hirulog and early reperfusion or occlusion (HERO)-2 trial investigators.Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction:the HERO-2 randomised trial.Lancet,2001,348:1855-1863.
8[8]Mehta SR,Eikelboom JW,Rupprecht H J,et al.Efficacy of hirudin in reducing cardiovascular events in patients with acute coronary syndrome undergoing early percutaneous coronary intervention.Eur Heart J,2002,23:117-123.
9[9]Bittl JA,Strony J,Brinker JA,et al.Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or post infarction angina.Hirulog Angioplasty Study Investigators.N Engl J Med,1995,333:764-769.
10[10]Bittl JA,Chaitman BR,Feit F,et al.Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina:Final report reanalysis of the bivalirudin angioplasty study.Am Heart J,2001,141:952-959.